Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma

Journal of Urology

Volumn 161, Issue 1, 1999, Pages 182-187

  Adler, Howard L ^b   McCurdy, Mark A ^b   Kattan, Michael W ^b   Timme, Terry L ^b   Scardino, Peter T ^b   Thompson, Timothy C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Interleukin 6; Prostatic neoplasms; Transforming growth factor beta

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; PROSTATE SPECIFIC ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; BODY BURDEN; BONE METASTASIS; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

EID: 0032830265     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62092-5     Document Type: Article

References (31)

1. Balkwill, F. R. and Burke, F.: The cytokine network. Immunol. Today, 10: 299, 1989.
2. Paul, W. E.: Pleiotropy and redundancy: T cell derived lymphokines in the immune response. Cell, 57: 521, 1989.
3. O'Garra, A.: Interleukins and the immune system 2. Lancet, 1: 1003, 1989.
4. Balkwill, F., Osborne, R., Burke, F., Naylor, S., Talbot, D., Durbin, H., Tavernier, J. and Fiers, W.: Evidence for tumor necrosis factor/cachectin production in cancer. Lancet, 2:1229, 1987.
5. Garcia, F. U., Chen, H. L. and Hunt, J. S.: Tumor necrosis factor-alpha (TNF): expression in prostate cancer. Proc. Annu. Meet. Amer. Assn. Cancer Res., 36: A1626, 1995.
6. Nakashima, J., Tachibana, M., Ueno, M., Baba, S. and Tazaki, H.: Tumor necrosis factor and coagulopathy in patients with prostate cancer. Cancer Res., 55: 4881, 1995.
7. Siegall, C. B., Schwab, G., Nordan, R. P., Fitzgerald, D. J. and Pastan, I.: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res., 50: 7786, 1990.
8. Okamoto, M., Lee, C. and Oyasu, R.: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57: 141, 1997.
9. Lang, S. H., Miller, W. R., Duncan, W. and Habib, F. K: Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer, 59: 235, 1994.
10. Rokhlin, O. W., Griebling, T. L., Karassina, N. V., Raines, M. A. and Cohen, M. B.: Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res., 16: 557, 1996.
11. Twillie, D. A., Eisenberger, M. A., Carducci, M. A., Hsieh, W., Kim, W. Y. and Simons, J. W.: Interleukin-6: A candidate mediator of human prostate cancer morbidity. Urology, 45: 542, 1995.
12. Hoosein, N., Abdul, M., McCabe, R., Gero, E., Deftos, L., Banks, M., Hodges, S., Finn, L. and Logothetis, C.: Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer. Urol. Oncol., 1: 246, 1995.
13. Thompson, T. C., Truong, L. D., Timme, T. L., Kadmon, D. K., McCune, B. K., Flanders, K. C., Scardino, P. T. and Park, S. H.: Transforming growth factor β1 as a biomarker for prostate cancer. J. Cell. Biochem., suppl., 16H: 54, 1992.
14. Truong, L. D., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T. and Thompson, T. C.: Association of transforming growth factor-β1 with prostate cancer. Hum. Path., 24: 4, 1993.
15. Eastham, J. A., Truong, L. D., Rogers, E., Kattan, M., Flanders, K. C., Scardino, P. T. and Thompson, T. C.: Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab. Invest., 73: 628, 1995.
16. Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M. and Geliebter, J.: Elevated levels of TGF-β1 in patients with invasive prostate cancer. Nature Med., 1: 282, 1995.
17. Kakehi, Y., Oka, H., Mitsumori, K., Itoh, N., Ogawa, O. and Yoshida, O.: Elevation of serum transforming growth factor-β1 level in patients with metastatic prostate cancer. Urol. Oncol., 2: 131, 1996.
18. Perry, K. T., Anthony, C. T., Case, T. and Steiner, M. S.: Transforming growth factor beta as a clinical biomarker for prostate cancer. Urology, 49: 151, 1997.
19. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The new American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer: clinicopathologic correlations. Cancer, 73: 104, 1994.
20. Moradi, M. M., Carson, L. F., Weinberg, J. B., Haney, A. F., Twiggs, L. B. and Ramakrishnan, S.: Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer, 72: 2433, 1993.
21. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H. and Pollak, M.: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279: 563, 1998.
22. Okamoto, M., Lee, C. and Oyasu, R.: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57: 141, 1997.
23. Gridley, D. S., Slater, J. D., Yonemoto, L. T., Miller, D. W., Rossi, C., Archambeau, J. O., Andres, M. L., Oey, M. and Slater, J. M.: Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy. Int. J. Oncol., 8: 175, 1996.
24. Fajardo, L. F., Kwan, H. H., Kolkowski, J., Prionas, S. D. and Allison, A. C.: Dual role of tumor necrosis factor-α in angiogenesis. Amer. J. Pathol., 140: 539, 1992.
25. Yang, E. Y. and Moses, H. L.: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallontoic membrane. J. Cell. Biol., 111: 731, 1990.
26. Miyazano, K., Hellman, U., Wernstedt, C. and Carl-Henrik, H.: Latent high molecular weight complex of transforming growth factor β1: purification from human platelets and structural characterization. J. Cell. Biol., 263: 6407, 1988.
27. Shirai, Y., Kawata, S., Ito, N., Tamura, S., Takaishi, K., Kiso, S., Tsushima, H. and Matsuzawa, Y.: Elevated levels of plasma transforming growth factor-β in patients with hepatocellular carcinoma. Jpn. J. Cancer Res., 83: 676, 1992.
28. Kong, F.-M., Anscher, M. S., Murase, T., Abbott, B. D., Inglehart, J. D. and Jirtle, R. L.: Elevated plasma transforming growth factor-β1 levels in breast cancer patients after surgical removal of the tumor. Ann. Surg., 222: 155, 1995.
29. Marie, C., Cavaillon, J.-M. and Losser, M.-R.: Elevated levels of circulating transforming growth factor-β1 in patients with the sepsis syndrome. Ann. Int. Med., 125: 520, 1996.
30. Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kios, S., Imai, Y., Shimomukai, H., Nomura, Y., Matsuda, Y. and Matsuzawa, Y.: High levels of transforming growth factor β1 in patients with colorectal cancer: Association with disease progression. Gastroenterology, 110: 375, 1996.
31. Muir, G. H., Butta, A., Shearer, R. J., Fisher, C., Dearnaley, D. P., Flanders, K. C., Sporn, M. B. and Colletta, A. A.: Induction of transforming growth factor beta in hormonally treated human prostate cancer. Brit. J. Cancer, 69: 130, 1994.